Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008



Similar documents
Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R DEA Rules - Objectives. DEA Rules

PHARMACY TECHNICIAN LICENSURE S.B. 92: ANALYSIS AS ENACTED

ANALYSIS AS REPORTED FROM COMMITTEE

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility DEA Audits. Scheduled/Controlled Drugs

REVIEW OF FEDERAL LAW FOR PHARMACY TECHNICIANS DR. SULLIVAN S MONOGRAPH

NH Laws / Rules Regarding Limited Retail Drug Distributors

Narcotic Treatment Programs

What Every Practitioner Needs to Know About Controlled Substance Prescribing

How To Get A Prescription In Rhode Island

12 LC S. The House Committee on Health and Human Services offers the following substitute to HB 972: A BILL TO BE ENTITLED AN ACT

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:

Keweenaw Holistic Family Medicine Patient Registration Form

Patient access to medical records

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Drug Diversion. Controlled Substance Prescribing and Diversion

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

WASHINGTON LAWS, 1987

Professional Roles in Nursing Practice. Legal and Ethical Principles and Values

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication

2014, That Was The Year That Was Greg Baran, RPh, MA, FMPA Baran Consulting LLC

Prescription Drug Monitoring Program Annual Report

ALABAMA BOARD OF MEDICAL EXAMINERS ADMINISTRATIVE CODE CHAPTER 540-X-8 ADVANCED PRACTICE NURSES: COLLABORATIVE PRACTICE TABLE OF CONTENTS

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

GEORGIA ~ STATUTE. Georgia Code Annotated (DEA registration); et seq; et seq (medical board provisions; PA committee)

Topics in Pharmacy Technician and Intern Laws for Ohio Pharmacists

Table of Contents. 2 P a g e

Pharmacy Program Pre-Test

COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS

COLORADO MEDICAL BOARD RULES AND REGULATIONS FOR LICENSURE OF AND PRACTICE BY PHYSICIAN ASSISTANTS (PAs) INTRODUCTION

SPECIAL USE AUTHORIZATION APPLICATION (Instructions to Applicants)

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

13 LC S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT

RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS

Strategies for Electronic Exchange of Substance Abuse Treatment Records

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

11 MEDICATION MANAGEMENT

- 1 - First Time Pharmacy Managers (Revised 02/02/2011)

Patient Information Form Trinity Wellness Center. Insurance Information

AMERICAN PSYCHOLOGICAL ASSOCIATION

Prescribing Standards for Nurse Practitioners (NPs)

CHAPTER 101 (HB 500)

State of Utah Department of Commerce Division of Occupational and Professional Licensing

Investigational Drugs: Investigational Drugs and Biologics

2015 REPORT Steven W. Schierholt, Esq. Executive Director

247 CMR: BOARD OF REGISTRATION IN PHARMACY

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

CHAPTER 10 PHARMACY TECHNICIAN REGULATIONS. These regulations are promulgated as authorized by the Act.

ALABAMA BOARD OF NURSING ADMINISTRATIVE CODE CHAPTER 610-X-5 ADVANCED PRACTICE NURSING COLLABORATIVE PRACTICE TABLE OF CONTENTS

DIVISION OF CORPORATIONS, BUSINESS AND PROFESSIONAL P.O. BOX JUNEAU, ALASKA ALASKA STATE BOARD OF PHARMACY

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

RADIOGRAPHER LICENSE AND LIMITED X-RAY MACHINE OPERATOR PERMIT

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Exempted acts; exemption from registration fees; definition

ExCPT Certified Pharmacy Technician (CPhT) Detailed Test Plan* 100 scored items, 20 pretest items Exam time: 2 hours 10 minutes

REGISTERED NURSE ANESTHETIST APPLICATION

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

KENTUCKY ADMINISTRATIVE REGULATIONS TITLE 201. GENERAL GOVERNMENT CABINET CHAPTER 9. BOARD OF MEDICAL LICENSURE

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations

CURES Prescription Drug Monitoring Program

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

CHAPTER 131. SENATE BILL No. 33

REGULATION 3 PHARMACY TECHNICIANS

RULES AND REGULATIONS FOR LICENSING DOCTORS OF ACUPUNCTURE AND ACUPUNCTURE ASSISTANTS (R ACU)

CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS

Healthcare Math: Calculating Dosage

Methadone Maintenance Treatment for Opioid Dependence

Medicare Advantage and Part D Fraud, Waste, and Abuse Training. October 2010

IACP Comparison of 503A and 503B The Drug Quality and Security Act of 2013

TEXAS ~ STATUTE Continued

(PLEASE TYPE OR PRINT IN INK) PART I - ALL APPLICANTS MUST COMPLETE:

NOTE: In the event that the seal is accidentally broken, the narcotic may be wasted via narcotic wastage procedures.

UW School of Dentistry Comprehensive Medication Policy

AMERICAN NATIONAL INSURANCE COMPANY CREDIT INSURANCE DIVISION P. O. BOX * SAN ANTONIO, TEXAS

Chapter 57 Respiratory Care Practices Act

House Study Bill Introduced

Information for Pharmacists

ADOPTED REGULATION OF THE BOARD OF OCCUPATIONAL THERAPY. LCB File No. R Effective October 24, 2014

Chapter 11 The Practice of Physician Assistants

U.S. Bureau of Labor Statistics. Pharmacy Tech

Prescriptive Authority Frequently Asked Questions Mandated by Senate Bill 406

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution

CONNECTICUT. Downloaded January D8T. CHRONIC AND CONVALESCENT NURSING HOMES AND REST HOMES WITH NURSING SUPERVISION

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

Transcription:

Pharmacy 543 Pharmacy Laws & Ethics MIDTERM EXAMINATION October 27, 2008 Name: Last First Student Number Questions 1-30 are multiple choice. Please record your answers on Side 2 of a Standard Answer Sheet, Form 1158. Follow the instructions on Side 1. Carefully complete your name and student number (both characters and bubbles). Select the BEST answer from the available choices. Multiple choice, one point each 30 points. Questions 31-35 are short-answer, 10 points. Ethics question, 10 points. Exam total: 50 points. Legibility: please verify that your written answers can be read by mere mortals, and your name and student ID number are legible, correct, and present on any papers you turn in. Please double-check your student ID number for accuracy. Errors or omissions may delay or impact your grade. Turn in: (1) the Standard Answer Form, (2) your answers to the short answer questions (1 sheet 2 sides) and the ethics question (1 sheet 2 sides) (3) other pages as necessary (see below). Please DO NOT turn in pages that do NOT need to be graded. You may NOT ask questions during the exam. However, if you believe that a question is technically flawed, please circle the faulty question number and briefly describe your concern. Turn in that (those) exam page(s) and your concerns will be addressed. So as to NOT confuse you, terms like NOT, TRUE, FALSE are presented in BOLD, ALL-CAPS. MULTIPLE CHOICE QUESTIONS 1. The role of the administrative branch of federal or state government is to: a. Enact the law b. Interpret the law c. Implement the law d. Formulate the law 2. The Tenth Amendment to the Constitution gives the states the right to legislate in all areas except those specifically prohibited or given to the US Congress in the Constitution. Which of the following is a PERMITTED state legislative activity? a. Regulate interstate commerce b. Regulate healthcare professions c. Raise armies d. Coin money Page 1 of 10

3. Common law is: I. A tradition derived from Napoleonic Law in France II. Applicable throughout the United States III. Relies on precedent in establishing a standard for future decisions d. I, II and III 4. *Were you to violate a rule in the practice of pharmacy, you could be involved in which of the following proceedings? I. Criminal II. Civil III. Administrative d. I, II and III 5. Which is TRUE about federal and state laws when they are in conflict? I. Federal laws prevail when permitted in the Constitution II. State laws always prevail III. State laws prevail if more restrictive c. III only d. I and III only e. I, II and III 6. The powers of Washington s Board of Pharmacy include promulgation of rules for all EXCEPT: a. Wholesaling of drugs and medical devices by pharmacists b. Establish criteria for valid prescriptions c. Distribution of drugs and medical devices by physicians d. Establish the qualifications for licensure of pharmacists or pharmacy interns 7. Which of the following is required to be registered with the Drug Enforcement Administration in order to participate in the manufacture, prescribing or dispensing of controlled substances? I. Pharmacists II. Pharmacy Technicians III. Pharmacies c. I and III d. I, II, and III Page 2 of 10

Name: Last First Student Number 8. When the Administrator of the DEA has proposed to revoke the DEA registration of a pharmacy, who has the burden of proof that this pharmacy should no longer have the registration? a. The DEA b. The pharmacy 9. Which DEA registrants are required to provide the following security measures to protect their controlled substances: alarms, perimeter security, locked cages? a. Wholesalers b. Pharmacies c. Narcotic Treatment Programs d. Physicians 10. On 12/31/2008 you find that you are running out of pharmacy storage space for prescriptions so you decide to shred some of your older controlled substance prescriptions. The DEA would have NO reason to object if you destroyed all prescriptions that had been written earlier than which of the following dates? a. 12/31/07 b. 06/30/07 c. 12/31/06 d. 06/30/06 11. When performing your required DEA inventory, for which of the following must you record an exact count? a. Oxycodone 5 mg/apap 325 mg (C-II) b. Hydrocodone 10 mg/apap 650 mg (C-III) c. Tylenol Elixir with Codeine 12 mg/5ml (C-V) d. Diazepam 10 mg (C-IV) 12. When the DEA schedules a drug that was previously NOT designated as a controlled substance, when is a pharmacy required to inventory the supply of this drug that it has in stock? a. On the day that the DEA scheduled the drug. b. Within 30 days of the date of the DEA's action. c. Within 60 days of the date of the DEA's action. d. Within 90 days of the date of the DEA's action. 13. You receive a prescription for Hydrocodone 10 mg/apap 650 mg tablets No. 30. (C-III) You have only 15 tablets in stock. How much time do you have to supply the remaining 15 tablets? a. 3 days b. 5 days c. 7 days d. 180 days Page 3 of 10

14. You send a DEA Form 222 to a wholesaler to order drugs but the company does not have one of the requested items in current stock. How long does the wholesaler have to supply this drug? a. 3 days b. 7 days c. 30 days d. 60 days 15. Which of the following is a valid DEA number for Dr. Evelyn Johnson, pediatrician. a. AJ 1234564 b. MJ1234563 c. AJ 1234563 d. AE1234563 16. Which federal official has the authority to define, by rule, an "emergency situation" as this term is used in the Controlled Substances Act? a. The Attorney General b. The Secretary of Health & Human Services c. The DEA Administrator d. The U. S. Surgeon General 17. Which of the following is a requirement for a pharmacist to be able to legally fill a verbal prescription for a Schedule II drug? I. Immediate administration of the drug is necessary II. No alternative treatment is available III. It is not reasonably possible for the prescriber to provide a written prescription c. I and III d. I, II, and III 18. In which of the following medical conditions is it legal to prescribe a Schedule II stimulant drug in Washington State? a. Narcolepsy b. Cerebral Palsy c. A.I.D.S. d. Glaucoma 19. A hard copy prescription for a controlled substance must contain all of the following EXCEPT: a. The prescriber's address b. Date of issue c. The symbols C-II, C-III, C-IV or C-V d. The prescriber's DEA number 20. Which of the following is NOT a Schedule III drug? a. Hydrocodone 5mg with Acetaminophen 325 mg tablets b. Marinol (dronabinol) capsules c. Testosterone 10 mg tablets d. Valium (diazepam) 5 mg tablets Page 4 of 10

Name: Last First Student Number 21. Which of the following practitioners are considered to be EXEMPT from registration by the DEA? I. A physician in the U. S. Army II. An Advanced Registered Nurse Practitioner employed by an Indian Tribe III. A dentist in the U. S. Public Health Service d. I, II, and III 22. You have dispensed the following prescription calling for Hydrocodone 5 mg and Acetaminophen 325 mg tablets, No. 60, Refill 3 times, Sig: Take 1 tablet every 4 hours as needed for pain. (C-III) Assuming that you dispensed 60 tablets originally, how many times, prior to the expiration of the prescription, may you dispense partial refills if you dispensed 30 tablets with each subsequent refill. a. 2 times b. 4 times c. 6 times total 240-60 = 180; 180/30=6 d. 8 times 23. A prescriber FAXed a prescription to your pharmacy for Morphine Sulfate Tablets sustained release 10 mg, No. 100, Sig: Take 1 tablet every 12 hours for pain. The prescription is for a hospice patient. You are allowed to fill the prescription as follows: a. Only a 72-hour emergency supply may be dispensed b. Only a 7 day supply may be dispensed c. Only 21 day supply may be dispensed d. The full quantity may be dispensed 24. The three ethical principles for conducting behavioral research established by the Belmont Report were: a. Respect for persons, virtue and trust b. Beneficence, justice and trust c. Respect for persons, beneficence, justice d. Beneficence, justice and virtue 25. Justice, in the context of biomedical ethics, refers to: a. Making decisions that are fair to the patient b. Ensuring the fair distribution of society s goods c. Ensuring equal distribution of society s goods d. Doing things in accordance with existing law Page 5 of 10

26. When would it be OK to administer an experimental therapy to a patient WITHOUT her/his consent? I. The health care provider believes that the patient would refuse therapy if the therapy s potential adverse events were disclosed II. The therapy to be provided represents standard of care III. The patient is unconscious and failure to treat would lead to serious harm d. I, II and III 27. To whom of the following could prescription information NOT be provided WITHOUT a patient s authorization? a. Medical personnel treating an immediate, life-threatening condition b. An FDA investigator exploring drug manufacturing problems c. A county sheriff d. A researcher operating under an approved Institutional Review Board protocol 28. A Board of Pharmacy investigator presents her credentials and asks to be admitted to the pharmacy to review specified prescription records. What should you do? a. Stall the investigator until your attorney arrives b. Admit the investigator c. Request to see a search warrant d. Request to see consent forms for the specified prescription records 29. If the Board of Pharmacy promulgated a rule prohibiting physicians from dispensing controlled substances and the rule was challenged by physicians, which of the following reasons might a judge give for overturning the rule? I. The Board had exceeded its statutory authority II. The Board had made an error of law III. The Board made a procedural error d. I, II and III 30. Which of the following are required for compliance with Washington rules when compounding a commercially available prescription drug? I. Authorization by the prescriber II. Ingredients are listed in an official compendium III. Patient agrees d. I, II and III Page 6 of 10

Name: Last First Student Number Short Answer Questions. Answers written outside the provided space will not be graded. 31. Susan Morrison comes to your pharmacy requesting that you fill a prescription for her that she's received previously from a different pharmacy. As the RECEIVING pharmacist, please fill in the missing items on the transferred prescription below for a non-controlled substance prescription. (2 points) Susan Morrison Today's date: 10/27/2008 TRANSFER Synthroid 25 mcg #30 Sig: Take one tablet by mouth once daily Dr. Jack Chen Issue date of original prescription: 8/15/2008 11 refills on original prescription Originally dispensed on 8/30/2008 Transferor Pharmacist: Mike Cheadle 153 First Avenue Seattle, WA 98105 DEA number: MC2468759 Number of remaining refills \ Date and location(s) of all refills 32. Your colleague at the pharmacy is confused about what protected health information (PHI) she can disclose to another person without the patient's prior authorization. Help her by giving her two examples of situations where it is permissible to use and disclose PHI under applicable HIPAA rules. (2 points) a. Treatment \ payment \ health care operations b. 33. A state passed a law to the effect that a pharmacist could refill a Schedule II prescription two times when the patient requires continual use of the medication. (A) Would you comply with the state law? (B) Explain the legal principle that supports your decision. (2 points) a. No, Federal law doesn't permit refills (1 pt) b. Doctrine of preemption (1 pt) unless state law is more restrictive, which it isn't in this case (1 pt) Page 7 of 10

34. Please complete the following table with the list of the remaining four classes of prescription medications and their respective time limits / expirations in Washington. Follow the example provided. (2 points) Prescription Medication Class Schedule II Schedule III Schedule IV Schedule V Legend drug Washington Time Limit / Expiration 12 months 6 months 6 months 12 months 12 months 35. Mary Johnson is a patient who you've been seeing in your pharmacy for several years. She enters your pharmacy and hands you a new prescription. You notice that the prescriber has written for oxycodone 10mg, which you do not have available in your pharmacy - you only stock the 5mg strength. You also notice another error on the prescription. Please update the prescription below according to what is allowed for a pharmacist to change on a Schedule II controlled substance prescription. You may also indicate if something is incorrect that you cannot change (2 points, ½ point will be deducted for each incorrect recommendation) Patient name: Mary Johnson Patient DOB: 4/24/1956 Patient address: 2868 Oak St. Seattle, WA 98105 Date: 10/27/2008 Oxycodone 10mg #30 Sig: I tablet PO Q4hrs PRN pain Refill: 2 Dr. Keith Monroe (signature) DEA # AM2468759 525 Madison Ave. Seattle, WA 98105 Change strength to 5 mg, quantity to 60 and sig to 2 tablets; eliminate refills Page 8 of 10

Name: Last First Student Number Ethics Question. Answers written outside the provided space will not be graded. Evaluate issues of pharmacy practice law regarding the following, abstracted from a January 2008 news release from the US Food and Drug Administration. (2) The U.S. Food and Drug Administration (FDA) sent letters warning seven pharmacy operations that the claims they make about the safety and effectiveness of their so-called "bio-identical hormone replacement therapy," or "BHRT" products are unsupported by medical evidence, and are considered false and misleading by the agency. FDA is concerned that unfounded claims like these mislead women and health care professionals. The pharmacy operations improperly claim that their drugs, which contain hormones such as estrogen, progesterone, and estriol (which is not a component of an FDA-approved drug and has not been proven safe and effective for any use) are superior to FDA-approved menopausal hormone therapy drugs and prevent or treat serious diseases, including Alzheimer's disease, stroke, and various forms of cancer. FDA is concerned that the claims for safety, effectiveness, and superiority that these pharmacy operations are making mislead patients, as well as doctors and other health care professionals. Compounded drugs are not reviewed by the FDA for safety and effectiveness, and FDA encourages patients to use FDA-approved drugs whenever possible. The warning letters state that the pharmacy operations violate federal law by making false and misleading claims about their hormone therapy drugs... The pharmacy operations compound hormone therapy drugs that contain estriol as well as progesterone and estrogen. No drug product containing estriol has been approved by FDA and the safety and effectiveness of estriol is unknown... FDA also responded today to a citizen petition from Wyeth, Madison, NJ, asking FDA to take regulatory action against compounding pharmacy operations that produce compounded "BHRT" drugs. Other stakeholders, including health care providers and consumer groups, have also raised concerns about "BHRT" drugs... confined to WA s practice act and associated rules would it be OK if there was a valid prescriber-patient-pharmacist relationship? (Yes) advertising restrictions in WA compendial status of ingredients adequate drug compounding controls 246-878-100 Evaluate the ethical considerations for preparing the medication given the circumstances above. inside the box. (8 points) Stay Describe the dilemma Perspective Beneficence Page 9 of 10

Nonmaleficence Autonomy Justice Virtue Root Cause Page 10 of 10